Man-made antibodies

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Nature

• Publication date

  1991-01-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/349293A0PMID 1987490
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequences of proteins of immunological interest

  1991cited by this paper
• Biological properties of a CD4 immunoadhesin

  1990cited by this paper
• Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme.

  1990cited by this paper
• Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor.

  1990cited by this paper
• Phage antibodies: filamentous phage displaying antibody variable domains

  1990cited by this paper
• A single-step procedure for cloning and selection of antibody-secreting hybridomas.

  1990cited by this paper
• A comparison of strategies to stabilize immunoglobulin Fv-fragments.

  1990cited by this paper
• A History of Immunology

  1989cited by this paper
• Conformations of immunoglobulin hypervariable regions

  1989cited by this paper
• A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin

  1989cited by this paper
• Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

  1989cited by this paper
• Correct folding of circularly permuted variants of a beta alpha barrel enzyme in vivo.

  1989cited by this paper
• A repertoire of monoclonal antibodies with human heavy chains from transgenic mice.

  1989cited by this paper
• Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.

  1989cited by this paper
• Development of biologically active peptides based on antibody structure.

  1989cited by this paper
• A humanized antibody that binds to the interleukin 2 receptor.

  1989cited by this paper
• Immune Network Theory

  1989cited by this paper
• The immunogenicity of chimeric antibodies

  1989cited by this paper
• Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library.

  1989cited by this paper
• Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab fragments in Escherichia coli.

  1989cited by this paper
• Direct cDNA cloning of the rearranged immunoglobulin variable region.

  1989cited by this paper
• Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction.

  1989cited by this paper
• Generation of a catalytic antibody by site-directed mutagenesis.

  1989cited by this paper
• Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

  1989cited by this paper
• Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda.

  1989cited by this paper
• Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways.

  1989cited by this paper
• A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen.

  1989cited by this paper
• 8 – Development of the Chicken Antibody Repertoire

  1989cited by this paper
• Expression and Secretion of Repertoires of VH Domains in Escherichia Coli : Isolation of Antigen Binding Activities

  1989cited by this paper
• A shadow over immunoassay

  1989cited by this paper
• Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

  1988cited by this paper
• The 14th barrel rolls out

  1988cited by this paper
• Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

  1988cited by this paper
• The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

  1988cited by this paper
• Single-chain antigen-binding proteins.

  1988cited by this paper
• A cytotoxic agent can be generated selectively at cancer sites.

  1988cited by this paper
• Protein structure: the 14th barrel rolls out.

  1988cited by this paper
• Localization of the binding site for the human high-affinity Fc receptor on IgG

  1988cited by this paper
• Transfer of a functional human immune system to mice with severe combined immunodeficiency

  1988cited by this paper
• Assembly of a functional immunoglobulin Fv fragment in Escherichia coli.

  1988cited by this paper
• Reshaping human antibodies for therapy

  1988cited by this paper
• The Dynamic Nature of the Antibody Repertoire

  1988cited by this paper
• Expression of an antibody Fv fragment in myeloma cells.

  1988cited by this paper
• Reshaping human antibodies: grafting an antilysozyme activity.

  1988cited by this paper
• A new means of inducibly inactivating a cellular protein

  1988cited by this paper
• The binding site for C1q on IgG

  1988cited by this paper
• Escherichia coli secretion of an active chimeric antibody fragment.

  1988cited by this paper
• Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.

  1987cited by this paper
• Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies

  1987cited by this paper
• Construction and expression of a recombinant antibody-targeted plasminogen activator.

  1987cited by this paper
• Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering

  1987cited by this paper
• Immunoglobulin chain recombination among antidigoxin antibodies by hybridoma-hybridoma fusion.

  1987cited by this paper
• Timing, Genetic Requirements and Functional Consequences of Somatic Hypermutation during B‐Cell Development

  1987cited by this paper
• Mutation Drift and Repertoire Shift in the Maturation of the Immune Response

  1987cited by this paper
• Antibody directed enzymes revive anti-cancer prodrugs concept.

  1987cited by this paper
• Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.

  1986cited by this paper
• Bispecific monoclonal antibodies from hybrid hybridomas.

  1986cited by this paper
• Catalytic antibodies.

  1986cited by this paper
• Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV.

  1986cited by this paper
• Inhibition of complement activation by IgG4 antibodies.

  1986cited by this paper
• [17] Bispecific monoclonal antibodies from hybrid hybridomas

  1986cited by this paper
• Selective chemical catalysis by an antibody.

  1986cited by this paper
• Replacing the complementarity-determining regions in a human antibody with those from a mouse

  1986cited by this paper
• Modelling of the combining sites of three anti‐lysozyme monoclonal antibodies and of the complex between one of the antibodies and its epitope.

  1986cited by this paper
• Immunotoxins.

  1985cited by this paper
• Linker Technology: Antibody-Mediated Delivery Systems

  1985cited by this paper
• A hapten-specific chimaeric IgE antibody with human physiological effector function

  1985cited by this paper
• Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments.

  1985cited by this paper
• Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli.

  1984cited by this paper
• Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin.

  1984cited by this paper
• Somatic mutation and the maturation of immune response to 2-phenyl oxazolone

  1984cited by this paper
• Frequency of expressed immunoglobulin light chain genes in lipopolysaccharide-stimulated BALB/c spleen cells

  1984cited by this paper
• Recombinant antibodies possessing novel effector functions

  1984cited by this paper
• Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in E. coli.

  1984cited by this paper
• Hybrid hybridomas and their use in immunohistochemistry

  1983cited by this paper
• Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

  1983cited by this paper
• Immunoglobulin gene expression in transformed lymphoid cells.

  1983cited by this paper
• Single amino acid substitution altering antigen-binding specificity.

  1982cited by this paper
• Immunoglobulin V region variants in hybridoma cells. I. Isolation of a variant with altered idiotypic and antigen binding specificity.

  1982cited by this paper
• Computer-generated schematic diagrams of protein structures.

  1982cited by this paper
• Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin new at 2.0 A resolution.

  1981cited by this paper
• Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution.

  1980cited by this paper
• Specific basophil hypersensitivity induced by skin testing and transferred using immune serum

  1975cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper
• Croonian lecture.—On immunity with special reference to cell life

  year unknowncited by this paper

• Expression and functional characterization of an anti-CD22 scFv targeting B-cell malignancies

  2025cites this paper
• Immuno-Graphene Field-Effect Transistor-Based Cortisol Bioelectronics Using a Novel Cortisol Antibody

  2025cites this paper
• Monoclonal antibodies for diagnosis of viral diseases: a comprehensive review

  2025cites this paper
• Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display.

  2025cites this paper
• Development of Sensitive and Specific Determination Methods of Bioactive Compounds Based on Generation of High-Performance Antibodies.

  2025cites this paper
• Technological advancements in antibody-based therapeutics for treatment of diseases

  2025cites this paper
• Identification of internalizing ScFvs for EGFR inhibition and apoptosis induction in cholangiocarcinoma cells

  2025cites this paper
• Structure-based design of antibody repertoires with drug-like properties

  2025cites this paper
• Deep mining of antibody phage-display selections using Oxford Nanopore Technologies and Dual Unique Molecular Identifiers.

  2024cites this paper
• Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review)

  2024cites this paper
• Therapeutic antibodies in oncology: an immunopharmacological overview

  2024cites this paper
• Structural basis of SARS-Cov-2 spike recognition by engineered synthetic multivalent VHH antibodies

  2024cites this paper
• Problems Facing Monoclonal Antibody Technology

  2024cites this paper
• A systemic approach to identifying sequence frameworks that decrease mAb production in a transient Chinese hamster ovary cell expression system

  2024cites this paper
• Molecular Dynamics Methods for Antibody Design.

  2023cites this paper
• Significance of antibody numbering systems in the development of antibody engineering

  2023cites this paper
• Biomarker Discovery by ORFeome Phage Display.

  2023cites this paper
• Bioengineering of Antibody Fragments: Challenges and Opportunities

  2023cites this paper
• Antibody Selection in Solution Using Magnetic Beads.

  2023cites this paper
• Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer

  2023cites this paper
• A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies

  2023cites this paper
• Evolution of chemistry and selection technology for DNA-encoded library

  2023cites this paper
• What Have We Learned from Design of Function in Large Proteins?

  2022cites this paper
• Site-Selective Lysine Acetylation of Human Immunoglobulin G for Immunoliposomes and Bispecific Antibody Complexes.

  2022cites this paper
• A novel platform for the production of autologous human antibodies

  2022cites this paper
• Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases—RA as a role model

  2022cites this paper
• Current innovative engineered antibodies.

  2022cites this paper
• An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages.

  2022cites this paper
• Hybridoma technology: is it still useful?

  2021cites this paper
• Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents

  2021cites this paper
• De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist

  2021cites this paper
• IsAb: a general in silico protocol for antibody design by

  2021cites this paper
• Disulfide-compatible phage-assisted continuous evolution in the periplasmic space

  2021cites this paper
• Bioorthogonal chemistry

  2021cites this paper
• Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

  2021cites this paper
• Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma

  2020cites this paper
• Current Applications of Pharmaceutical Biotechnology

  2020cites this paper
• A novel aptamer-based histochemistry assay for specific diagnosis of clinical breast cancer tissues

  2020cites this paper
• Viruses Masquerading as Antibodies in Biosensors: The Development of the Virus BioResistor.

  2020cites this paper
• COVID-19 Prophylaxis: The Desperate Need for Mankind

  2020cites this paper
• Current Development of Monoclonal Antibodies in Cancer Therapy.

  2020cites this paper
• Antibody Phage Display: Antibody Selection in Solution Using Biotinylated Antigens.

  2020cites this paper
• Phage Display Derived Monoclonal Antibodies: From Bench to Bedside

  2020cites this paper
• Ribosome Display Technology: Applications in Disease Diagnosis and Control

  2020cites this paper
• High-Throughput Generation of In Silico Derived Synthetic Antibodies via One-step Enzymatic DNA Assembly of Fragments

  2020cites this paper
• Harnessing Evolution to Make Medicines (Nobel Lecture).

  2019cites this paper
• Progress in the Development of Intrinsically Conducting Polymer Composites as Biosensors

  2019cites this paper
• Generation of Fabs-in-tandem immunoglobulin molecules for dual-specific targeting.

  2019cites this paper
• A High-Throughput Platform for the Generation of Synthetic Ab Clones by Single-Strand Site-Directed Mutagenesis

  2019cites this paper
• Medikamentenentwicklung mithilfe der Evolution (Nobel‐Vortrag)

  2019cites this paper
• Canine CD117-Specific Antibodies with Diverse Binding Properties Isolated from a Phage Display Library Using Cell-Based Biopanning

  2019cites this paper
• Improving the Bioprocessing of ADEPT Fusion Proteins using Ultra Scale-Down Techniques

  2019cites this paper
• TM4SF5 monoclonal antibody (anti-hTM4SF5 antibody) in human pancreatic cancer cell lines in vitro. Treatment with anti-hTM4SF5 antibody reduced cell viability, modulated the expression of EMT markers Vimentin and E-cadherin, and decreased cell motility in human pancreatic cancer cells

  2019cites this paper
• Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells

  2019cites this paper
• Harnessing Evolution to Make Medicines

  2019cites this paper
• Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation

  2019cites this paper
• Development of Foot-and-Mouth Disease Virus-Neutralizing Monoclonal Antibodies Derived From Plasmablasts of Infected Cattle and Their Germline Gene Usage

  2019cites this paper
• Therapeutic Antibody Engineering and Selection Strategies.

  2019cites this paper
• Generation of human and rabbit recombinant antibodies for the detection of Zearalenone by phage display antibody technology.

  2019cites this paper
• Development of antibodies against the Notch pathway ligand JAG1 using phage display technology

  2019cites this paper
• Third generation antibody discovery methods: in silico rational design.

  2018cites this paper
• DNA-Encoded Chemical Libraries: A Selection System Based on Endowing Organic Compounds with Amplifiable Information.

  2018cites this paper
• Development of a novel T cell engaging antibody derivative for local PD-1/PD-L1 immune checkpoint blockade in acute myeloid leukemia

  2018cites this paper
• RNA Aptamers with Specificity for Heparosan and Chondroitin Glycosaminoglycans

  2018cites this paper
• Estudo da interação do scFv do anticorpo Rituximab com a alça do receptor CD20: avaliação da energia livre de ligação pelo método ABF para proposição de biobetters

  2018cites this paper
• DNA‐encoded chemical libraries – achievements and remaining challenges

  2018cites this paper
• 5 Immunoaffinity Chromatography : A Review

  2018cites this paper
• Trends in recombinant protein use in animal production

  2017cites this paper
• Replacing reprogramming factors with antibodies selected from autocrine antibody libraries

  2017cites this paper
• Evidence Based Targeting of Cytokines for Conventional and the Potential Phytotherapies in Management of Rheumatoid Arthritis

  2017cites this paper
• POSTSURGICAL PAIN BY ADMINISTERING AN ANTI-NERVE GROWTH FACTOR ANTAGONSTANTIBODY

  2017cites this paper
• Decomposing Dynamical Couplings in Mutated scFv Antibody Fragments into Stabilizing and Destabilizing Effects.

  2017cites this paper
• A Highly Diverse and Functional Naïve Ubiquitin Variant Library for Generation of Intracellular Affinity Reagents.

  2017cites this paper
• Principles for computational design of binding antibodies

  2017cites this paper
• abYsis: Integrated Antibody Sequence and Structure-Management, Analysis, and Prediction.

  2017cites this paper
• The Use of Monoclonal Antibody G 250 in the Therapy of Renal-Cell Carcinoma

  2017cites this paper
• Optimizing antibody expression: The nuts and bolts.

  2017cites this paper
• Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy.

  2017cites this paper
• Antisoma Application: A Fully Integrated V-Like Antibodies Platform

  2017cites this paper
• Strategies for Selecting Membrane Protein-Specific Antibodies using Phage Display with Cell-Based Panning

  2017cites this paper
• Coming-of-Age of Antibodies in Cancer Therapeutics.

  2016cites this paper
• Fundamentos y casos exitosos de la biotecnología moderna

  2016cites this paper
• Selection of Recombinant Human Antibodies.

  2016cites this paper
• Generation and analyses of human synthetic antibody libraries and their application for protein microarrays.

  2016cites this paper
• Advances in Monoclonal Antibodies Production and Cancer Therapy

  2016cites this paper
• Biophysical characterization of antibodies with isothermal titration calorimetry

  2016cites this paper
• Assessment of antibody library diversity through next generation sequencing and technical error compensation

  2016cites this paper
• Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains

  2016cites this paper
• Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy

  2016cites this paper
• Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display

  2016cites this paper
• Antibody Humanization Techniques

  2016cites this paper
• Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy

  2016cites this paper
• Novel Antibody for the Treatment of Transthyretin Amyloidosis*

  2016cites this paper
• AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences

  2015cites this paper
• Advances in phage display technology for drug discovery

  2015cites this paper
• A Review on: Antibody Engineering for Development of Therapeutic Antibodies

  2015cites this paper
• Generation and analysis of the improved human HAL9/10 antibody phage display libraries

  2015cites this paper
• Current approaches in SELEX: An update to aptamer selection technology.

  2015cites this paper
• Scalable high throughput selection from phage-displayed synthetic antibody libraries.

  2015cites this paper
• Selections for Enzymatic Catalysts

  2015cites this paper